Loading...
ROCO
4109
Market cap33mUSD
Jul 09, Last price  
12.00TWD
1D
-0.41%
1Q
-3.61%
Jan 2017
-47.44%
IPO
-19.62%
Name

Jia Jie Biomedical Co Ltd

Chart & Performance

D1W1MN
ROCO:4109 chart
P/E
21.23
P/S
2.20
EPS
0.57
Div Yield, %
4.17%
Shrs. gr., 5y
11.79%
Rev. gr., 5y
12.42%
Revenues
485m
-9.62%
343,062,000270,290,000242,481,000317,716,000332,758,000537,070,000485,403,000
Net income
50m
-76.22%
-24,481,000-31,925,0005,340,000-5,470,000144,146,000211,372,00050,260,000
CFO
21m
-51.87%
24,712,00027,100,0004,373,000-8,778,000-4,488,00044,346,00021,343,000
Dividend
Sep 24, 20250.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jia Jie Biomedical Co., Ltd., headquartered in Kaohsiung, Taiwan, was established in 1995. Formerly known as Murad Chia Jei Biotechnology Co., Ltd. until its rebranding in June 2019, the company primarily specializes in the production and distribution of health foods and wellness products across both Taiwan and Mainland China. The company's core operations encompass the processing, sale, and trade of softshell turtle-derived food items, as well as the manufacturing of dairy products. Its diversified food portfolio also features a range of specialty items such as softshell turtle egg powder capsules, enzyme powders, tortoise jelly, softshell turtle oil, and various other encapsulated nutritional supplements. Beyond its food production, Jia Jie Biomedical engages in comprehensive import/export activities, product distribution, and managing bidding and quotation procedures for its offerings. It also operates as a wholesaler for a broad array of consumer goods, including non-alcoholic beverages, confectioneries, baked goods, dietary supplements, general groceries, everyday household items, and cosmetics. Further expanding its business scope, the company manufactures water purification systems and their associated components, provides brokerage services for life and property insurance, and invests in the research, development, and production of advanced aquatic product technologies and various biological solutions.
IPO date
Jan 02, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT